Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2025-04-01 Director's Dealing
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Report of proposed sale of securities 3 pages 139.2KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It contains detailed information about the filer, the securities to be sold, dates, amounts, and broker information. This form is used to notify the SEC and the public about insider or restricted stock sales, typically by officers or affiliates of the issuer. It is not an earnings release, annual report, or any other financial report but a regulatory filing related to insider transactions. Therefore, it fits best under the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length and content confirm it is the actual filing, not just an announcement or certification.
2025-04-01 English
Form 4 - Statement of Changes in Beneficial Ownership 2 pages 13.7KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). It reports changes in beneficial ownership of securities by an insider, specifically Michael J. Farrell, the CEO of ResMed Inc. The form details transactions involving the acquisition and disposition of company stock and stock options. This type of filing is used to disclose insider trades by directors and officers. The presence of transaction dates, security titles, and ownership details confirms it is a Director's Dealing report. It is not an earnings release, annual report, or any other type of financial or regulatory report. Therefore, the correct classification is Director's Dealing (DIRS). The document length and content fully support this classification with high confidence.
2025-03-11 English
NOTICE OF PROPOSED SALE OF SECURITIES 3 pages 137.9KB
Regulatory Filings Classification · 100% confidence The document is a Form 144 filing with the SEC, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It contains detailed information about the securities to be sold, the filer, acquisition details, and sale information. This type of filing is specifically related to insider or affiliate sales of securities and is not a financial report, earnings release, or management discussion. It is a regulatory filing notifying the SEC and the public about the proposed sale of restricted or control securities. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories.
2025-03-11 English
Statement of changes in beneficial ownership of securities 2 pages 17.3KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of company securities by insiders such as officers, directors, or significant shareholders. The document includes detailed tables of securities acquired or disposed of, transaction dates, prices, and ownership forms. It specifically reports insider transactions by Kaushik Ghoshal, Chief Commercial Officer of ResMed Inc. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document is not an annual report, earnings release, or any other type of financial or regulatory report but a specific insider transaction report under SEC Section 16(a). Therefore, the correct classification is DIRS (Director's Dealing). The document length and content fully support this classification with high confidence.
2025-03-11 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 2 pages 12.1KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of company securities by insiders such as officers, directors, or significant shareholders. The text includes details about a transaction by Brett Sandercock, Chief Financial Officer of ResMed Inc., reporting a sale of shares. This type of filing is specifically related to insider transactions and personal share dealings by company executives. Therefore, the document fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual Form 4 filing, not an announcement or summary.
2025-03-11 English
Form 144 - Notice of Proposed Sale of Securities 3 pages 135.9KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It contains detailed information about the filer, the securities to be sold, acquisition details, and sales in the past 3 months. This form is used to notify the SEC and the public about insider or restricted securities sales, which aligns with the definition of Director's Dealing (DIRS). The document is not an annual report, earnings release, or any other financial report but a regulatory filing specifically about insider share transactions.
2025-03-10 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.